VISCHER has advised Royalty Pharma Investments. Mintz and Schellenberg Wittmer have advised Neurimmune AG. Royalty Pharma Investments has acquired a portion of Neurimmune AG’s royalty interest...
Royalty Pharma Acquires Royalty Interest in Cliramitug from Neurimmune
ASTRA Therapeutics Secures CHF 7.75 Million in Seed Financing
VISCHER has advised ASTRA Therapeutics SA. ASTRA Therapeutics SA, a start-up specializing in the development of precision drugs targeting eukaryotic pathogens, has announced the successful completion...
University Hospital Basel Acquires St. Claraspital AG
VISCHER has advised St. Clara AG and the Ingenbohl Monastery. Bratschi advised and represented the University Hospital Basel in the merger proceedings before the COMCO. The...
Mosanna Therapeutics’s Seed Financing Round Extension
VISCHER advises Mosanna Therapeutics on the deal. Mosanna Therapeutics AG closes an extension of the Seed Financing Round with the investors Supermoon Capital and High-Tech Gründerfonds...
Eurocine Vaccines’ Research And Collaboration Agreement with Redbiotec
Vischer advised Redbiotec on the deal. Eurocine Vaccines and Redbiotec have signed a research and partnership agreement for the development of vaccine candidates against Herpes Simplex...
Anaveon’s CHF 110 Million Series B Financing Round
VISCHER advised Anaveon on the deal. Anaveon AG, a Swiss clinical-stage immuno-oncology company, has agreed to a CHF 110m Series B financing led by incoming investor...